Aetna Inc (AET) Shares Sold by KBC Group NV
KBC Group NV cut its position in Aetna Inc (NYSE:AET) by 26.5% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 291,767 shares of the company’s stock after selling 105,348 shares during the quarter. KBC Group NV’s holdings in Aetna were worth $52,632,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds also recently bought and sold shares of AET. GSA Capital Partners LLP purchased a new stake in Aetna during the 2nd quarter valued at approximately $350,000. BlueCrest Capital Management Ltd purchased a new stake in Aetna during the 2nd quarter valued at approximately $425,000. BB&T Investment Services Inc. purchased a new stake in Aetna during the 2nd quarter valued at approximately $245,000. National Asset Management Inc. raised its stake in Aetna by 4.3% during the 2nd quarter. National Asset Management Inc. now owns 2,859 shares of the company’s stock valued at $436,000 after acquiring an additional 119 shares during the last quarter. Finally, Colony Group LLC purchased a new stake in Aetna during the 2nd quarter valued at approximately $241,000. 87.41% of the stock is owned by hedge funds and other institutional investors.
Several research firms have commented on AET. Credit Suisse Group upped their price objective on Aetna from $200.00 to $208.00 and gave the company a “neutral” rating in a research note on Wednesday, January 31st. Piper Jaffray Companies reaffirmed a “buy” rating and set a $212.00 price objective on shares of Aetna in a research note on Tuesday, January 30th. Cowen reaffirmed a “buy” rating and set a $212.00 price objective on shares of Aetna in a research note on Tuesday, January 30th. Citigroup downgraded Aetna from a “buy” rating to a “neutral” rating and upped their price objective for the company from $187.89 to $212.00 in a research note on Wednesday, January 31st. Finally, Deutsche Bank raised Aetna from a “hold” rating to a “buy” rating and upped their price objective for the company from $195.00 to $212.00 in a research note on Monday, January 22nd. Ten investment analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company. Aetna presently has a consensus rating of “Buy” and a consensus price target of $185.94.
Aetna (NYSE:AET) last issued its earnings results on Tuesday, January 30th. The company reported $1.25 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.18 by $0.07. The business had revenue of $14.74 billion during the quarter, compared to the consensus estimate of $14.79 billion. Aetna had a return on equity of 21.50% and a net margin of 3.15%. The company’s revenue for the quarter was down 6.2% on a year-over-year basis. During the same period in the prior year, the business posted $0.08 EPS. research analysts anticipate that Aetna Inc will post 10.99 earnings per share for the current year.
The firm also recently announced a quarterly dividend, which was paid on Friday, January 26th. Stockholders of record on Thursday, January 11th were paid a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.13%. The ex-dividend date of this dividend was Wednesday, January 10th. Aetna’s dividend payout ratio (DPR) is 34.78%.
ILLEGAL ACTIVITY NOTICE: “Aetna Inc (AET) Shares Sold by KBC Group NV” was originally reported by Daily Political and is owned by of Daily Political. If you are viewing this piece of content on another publication, it was illegally stolen and republished in violation of international trademark and copyright legislation. The correct version of this piece of content can be accessed at https://www.dailypolitical.com/2018/02/10/aetna-inc-aet-shares-sold-by-kbc-group-nv.html.
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc (NYSE:AET).
Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with MarketBeat.com's FREE daily email newsletter.